Aristotle University Of Thessaloniki (AUTH)
Μελέτη του ιστικού παράγοντα στις διαταραχές του πηκτικού μηχανισμού σε ασθενείς με κίρρωση του ήπατος
Abstract
dc:descriptionIntroduction: Cirrhosis is characterized by significant perturbations of the coagulation mechanism. Tissue factor (TF) is the main activator molecule of the coagulation cascade. The main mode of TF activation is through its expression by microvesicles, establishing them as an important research focus in multiple prothrombotic syndromes. Therefore, their study may provide valuable insights into the hypercoagulability of cirrhosis and possible mechanisms by which it contributes to disease progression. Our study aimed to assess TF levels and activity of TF-expressing microvesicles in the plasma of cirrhotic patients and correlate them with disease severity. Materials & Methods: We prospectively enrolled 82 patients [11 with cirrhosis and hepatocellular cancer (group 1), 50 with cirrhosis (group 2) and 21 controls (group 3)]. Extensive workup for disease staging and exclusion criteria was undertaken. Exclusion criteria included thrombophilia, any history of thrombosis, recent hospitalisation, ongoing infection or excessive alcohol intake, cancer, haematological diseases and use of anticoagulant, antiplatelet or contraceptive drugs. Plasma tissue factor antigen concentration (TFag) and tissue factor-expressing plasma microvesicles (MV-TF) activity were assessed. Results: TFag median values were 71.2 [56.8-81.9], 59.7 [47.1-66.6] and 43.9 [29.4-47.9] pg/ml in the cirrhosis with HCC (group 1), cirrhosis without HCC (group 2) and control (group 3) groups, respectively. There was a statistically significant difference between groups 1 and 3 (p<0.001) and groups 2 and 3 (p<0.001), while group 1 had higher values than group 2 without statistical significance (p=0.133). MV-TF showed median values of 4.03 [3.35-4.92], 3.22 [2.44-4.09] and 2.17 [1.49-3.05] pg/ml in groups 1, 2 and 3 respectively. There was a statistically significant difference between groups 1 and 3 (p<0.001) and groups 2 and 3 (p=0.003), while group 1 had higher values than group 2 without statistical significance (p=0.088). In Group 2, the patients’ Child-Pugh (CP) stage was A in 56%, B in 26% and C in 18% of cases, while 50% of the patients had decompensated cirrhosis (DeCi). MV-TF activity significantly correlated with decompensated cirrhosis (p=0.005) and higher CP stage (p=0.011). Finally, MV-TF activity significantly correlated with 12-month mortality (p=0.021).Conclusions: MV-TF activity is elevated in patients with cirrhosis, showing a significant correlation with disease severity. The fact that all patients had stable disease indicates that these dynamics are intrinsic to cirrhosis and independent of acute complications. MV-TF may play an essential role in the procoagulant imbalance of liver cirrhosis and their contribution in disease progression should be studied further.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Protopapas, Adonis
- Πρωτοπαπάς, Άδωνις
Subjects
dc:subject × 22- Ιστικός παράγοντας
- Θρόμβωση
- Κίρρωση
- Προθρομβωτικός
- Μικροκυστίδια
- Ίνωση
- Αντιπηκτικά
- Tissue factor
- Thrombosis
- Anticoagulation
- Cirrhosis
- Procoagulant
- Microvesicles
- Fibrosis
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ηπατολογία
- Γαστροεντερολογία
- Clinical Medicine
- Medical and Health Sciences
- Hepatology
- Gastroenterology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58510